Forget Rescheduling: Green Thumb's Cash Flow Is the Real Reason to Own It

Green Thumb (GTBIF), a U.S. cannabis operator, reported 2025 GAAP earnings of $114.2M, operating cash flow of $294.9M, and normalized EBITDA of $348.4M. The company has repurchased $203.4M in stock. Q2 2026 EBITDA was $84.3M, with operating cash flow down to $104.8M. Federal rescheduling could boost profitability and stock price.

Original reporting
Published Oct 30, 2026, 7:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 7:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Forget Rescheduling: Green Thumb's Cash Flow Is the Real Reason to Own It — source image
Decision brief

The 30-second read

$GTBIFBullishLow
01

Why it matters

The disclosed earnings and cash flow data provide fresh insight into the company's financial health, influencing valuation models.

02

Market read

New earnings data for a profitable cannabis MSO could shift investor sentiment in the sector.

03

What to watch

Regulatory uncertainty remains high; any delay in federal rescheduling could suppress valuation despite strong cash flow.

Relevance 4/10Novelty 4/10Timing: today

Background

Green Thumb (GTBIF) is an OTC‑listed multi‑state cannabis operator with a market cap of about $1.4 billion.

Company-level read

Ticker impact

$GTBIFBullishHigh confidence
Context

The article reports Green Thumb's 2025 GAAP earnings, 2026 Q2 EBITDA, and cash flow figures, marking the first public disclosure of these financial results.

Expected impact

potential modest upside as investors value cash flow strength, tempered by pressure if cash flow weakness persists

Evidence & confidence

First-time earnings disclosure for a micro‑cap OTC stock provides new data; cash flow remains robust overall, supporting a bullish view, while the decline may limit gains.

Market effects

Highlights profitability potential in the cannabis sector, may prompt re‑rating of other cash‑flow positive MSOs.

U.S. cannabis investors may adjust exposure to profitable operators.

Limited to niche cannabis market; no broad macro impact.

Counterpoint

Cash flow decline could signal emerging operational challenges, suggesting a short‑term pullback.

Key entities

  • Green Thumb

    OTC‑listed cannabis operator reporting new financial results.

Related articles

Med

Green Thumb Industries Inc (GTBIF) (Q3 2026) Earnings Call Highlights: Revenue Climbs 11%

Green Thumb Industries (GTBIF) reported Q3 2026 revenue of $324M, up 11% YoY, with normalized EBITDA at $89M. Same-store sales grew 3%, and cash flow from operations was $58M. The company faces pricing pressure and regulatory uncertainty, with Q4 revenue expected to be flat. CEO Ben Kovler emphasized caution in capital allocation due to uncertainty. The company is expanding in markets like Virginia, Texas, and Florida, with plans for 3-5 Florida stores by year-end and 10+ in 2027.

$GTBIFMed

Green Thumb Industries Reports Third Quarter 2026 Results

Green Thumb Industries Inc. (GTBIF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Green Thumb Industries Reports Third Quarter 2026 Results CHICAGO and VANCOUVER, British Columbia, November 4, 2026 – Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis company with a portfolio of best

Med

Green Thumb Industries: Is This Profitable Cannabis Stock Still Undervalued?

Green Thumb Industries (GTBIF) reported Q2 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The company grew revenue by 4.6% YoY and maintains a strong balance sheet with $283.6M in cash and $283M in debt. It repurchased 7.9M shares in Q2. Despite challenges, its financial flexibility and potential federal reform make it a notable player in the cannabis industry.

$CURLFHighAI 9/10

The Cannabis M&A Wave Is Here. Curaleaf Proved It. Here's Whether Green Thumb Should Ride It -- or Wait to Be Swept Up.

Curaleaf (CURLF) has proposed a $260M takeover of Aurora Cannabis (ACB), offering 0.3463 shares and $0.75 cash per share. Aurora, despite financial struggles, is attractive for its European market share. Green Thumb Industries (GTBIF), a profitable U.S. cannabis retailer, may also pursue acquisitions post-rescheduling, focusing on smaller, strategic deals.

$GTBIFMed

Green Thumb Amends RYTHM Notes and Warrants, Removes Ownership Cap; $72M Notes Affected

Green Thumb Industries (GTBIF) amended its secured convertible notes, pre-funded warrants, and shared services agreement with RYTHM to remove a 49.99% beneficial ownership cap. The amendment affects $72.0M of original principal and warrants for up to 9,731,638 shares, effective Oct 10, 2026. Green Thumb will consolidate RYTHM from that date, without intending to exercise the securities.